Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New tubulin polymerization inhibitors covered by Zentaris patent

Feb. 26, 2004

AstraZeneca describes new MEK inhibitors with utility in solid tumor therapy

Feb. 26, 2004

MDM2 antagonists activate p53 tumor suppressor pathway in vivo

Feb. 26, 2004

NDA submission for six-month Eligard product

Feb. 25, 2004

Vidaza NDA accepted for filing

Feb. 25, 2004

Oral phenoxodiol evaluated in phase I trial for cervical cancer

Feb. 25, 2004

Thalomid sNDA accepted for review

Feb. 25, 2004

Novel antiproliferative agents in early development at Bayer

Feb. 25, 2004

New mitotic kinesin KSP inhibitors jointly reported by Cytokinetics and GSK

Feb. 25, 2004

New macrolide-containing conjugates and their use reported by Pliva

Feb. 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...